Status:
COMPLETED
Endoscopic Submucosal Dissection Versus Gastrectomy
Lead Sponsor:
Soonchunhyang University Hospital
Conditions:
Early Gastric Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
Gastrectomy is curative treatment for early gastric cancer (EGC). Recently, endoscopic submucosal dissection (ESD) has been accepted as standard treatment in selected patients with negligible risk of ...
Detailed Description
The prevalence of gastric cancer is high in Asia, especially in Korea and Japan. In Korea, the detection rate of EGC has increased with mass screening for the prevention of gastric cancer-related deat...
Eligibility Criteria
Inclusion
- differentiated type mucosal cancer without ulceration, regardless of tumor size
- differentiated type mucosal cancer with ulceration ≤ 3 cm in diameter
- superficial (SM1 \< 500 μm) submucosal cancer ≤ 3 cm in diameter
- undifferentiated type mucosal cancer without ulceration ≤ 2 cm in diameter
Exclusion
- early gastric cancer in a remnant stomach
- gastrectomy due to metachronous lesions during follow-up period
- post-ESD additional surgery due to high risk of lymph node metastasis or the possibility of residual tumor
Key Trial Info
Start Date :
May 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02216110
Start Date
May 1 2003
End Date
March 1 2015
Last Update
May 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soonchunhyang University Hospital
Seoul, South Korea